Solventum SOLV Add - Incremental shares under stock-based compensation plans (in shares)

Add - Incremental shares under stock-based compensation plans (in shares) at other companies

3MMMM

3.7M-5.1%

Medline, Inc. MDLN

——

Other financials

Income statement

See full

Revenue$2.0B-3.0%

Gross profit$1.1B-1.5%

Operating income$81.0M-46.7%

Net income$13.0M-90.5%

EPS (diluted)$0.07-91.0%

Balance sheet

See full

Cash & equivalents$561.0M+5.1%

Total debt$5.8B-26.8%

Total equity$5.0B+52.3%

Total assets$14.1B-3.0%

Cash flow

See full

Operating cash flow-$189.0M-752%

CapEx$84.0M-22.9%

Free cash flow-$273.0M-241%

Valuation

See full

Market cap$13.06B-13.9%

Enterprise value$18.29B-19.4%

P/E9.1×-30.9×

P/S1.6×-0.2×

Profitability

See full

Gross margin53.7%-0.9pp

Operating margin25.5%+15.8pp

Net margin17.3%+12.8pp

FCF margin4.6%-13.9pp

Returns & leverage

See full

Return on equity34.8%+24.1pp

Debt / equity1.2×-1.3×

Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's add - incremental shares under stock-based compensation plans (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solventum's add - incremental shares under stock-based compensation plans (in shares)?: Solventum (SOLV) reported add - incremental shares under stock-based compensation plans (in shares) of $1.3M in Q1 2026.
How has Solventum's add - incremental shares under stock-based compensation plans (in shares) changed year-over-year?: Solventum's add - incremental shares under stock-based compensation plans (in shares) increased by 18.2% year-over-year, from $1.1M to $1.3M.